15-min delayed · Jul 27, 3:45 PM ET · Get real-time quotes →
The Quantellect read.Of the 3 firms covering Diversified Healthcare Trust, 2 rate it Buy or better, 1 sit at Hold, and 0 rate it Sell or worse, a moderate buy consensus. Targets are tightly clustered, $8.00 to $11.00, so the covering firms are broadly aligned. The average target of $9.83 sits 5% above the current $9.40. The rating mix has held broadly steady over recent months. On the fundamentals, the Street sees consensus EPS building from about $-0.15 next quarter toward $-0.47 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS3 ratings
Moderate Buy
Strong Buy00%
Buy267%
Hold133%
Sell00%
Strong Sell00%
Based on 3 analysts giving stock ratings to Diversified Healthcare Trust.
As of Jul, 2 of 3 firms rate DHC a Buy (1 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
DHC EPS & revenue forecast
EPS · NEXT QUARTER
$-0.15
Range $-0.15 – $-0.15 · 2 analysts · -33% YoY
Next period, 2 analysts expect Diversified Healthcare Trust to earn $-0.15 a share (range $-0.15 – $-0.15), versus $-0.22 a year earlier. Full-year consensus is $-0.60, growing to $-0.47 the year after.
REVENUE · NEXT QUARTER
$377.8M
Range $367.2M – $392.9M · 2 analysts · -3% YoY
Revenue is expected to reach $377.8M (range $367.2M – $392.9M), -2.8% year-over-year. Full-year consensus is $1.5B, rising to $1.6B next year.
Top analysts covering Diversified Healthcare Trust
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on DHC.
#1
Michael Carroll
RBC Capital
Hold
$8.00-14.9% to target
Coverage
—
+ Follow
#2
JM
John Massocca
B. Riley Securities
Buy
$11.00+17.0% to target
Coverage
—
+ Follow
#3
MD
Michael Diana
Maxim Group
Buy
$10.50+11.7% to target
Coverage
—
+ Follow
DHC stock forecast FAQ
What is DHC's average 12-month price target?+
The 3 analysts with a live target average $9.83 for Diversified Healthcare Trust over the next 12 months, ranging from a $11.00 high to a $8.00 low.
Is DHC stock a Buy, Sell or Hold right now?+
The current consensus is Moderate Buy. Of the 3 analyst ratings, 2 are Buy or Strong Buy, 1 are Hold, and 0 are Sell or Strong Sell.
What are the highest and lowest price targets for DHC?+
The Street-high target is $11.00 (B. Riley Securities), and the Street-low is $8.00 (RBC Capital). The average of all 3 active targets is $9.83.
How many Wall Street analysts cover DHC?+
3 analysts have an active rating on Diversified Healthcare Trust, and 3 firms carry a live 12-month price target.
Who is the most accurate analyst covering DHC?+
Among analysts who currently cover DHC, Michael Carroll of RBC Capital has the strongest overall Quantellect track record. Their current call is Hold with a $8.00 target.
What is Diversified Healthcare Trust's projected EPS for next quarter?+
The consensus estimate is $-0.15 per share (range $-0.15 – $-0.15) across 2 analysts. Full-year EPS is projected at $-0.60, rising to $-0.47 the following year.
How much revenue is Diversified Healthcare Trust expected to report next quarter?+
Consensus revenue is $377.8M (range $367.2M – $392.9M). Full-year revenue is projected at $1.5B, growing to $1.6B next year.
Have analysts been upgrading or downgrading DHC lately?+
As of Jul, 2 of 3 firms rate DHC a Buy (1 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their DHC calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.
